Beranda › Leukemia Mieloid Akut › Florida › Tampa
Uji klinis Leukemia Mieloid Akut di Tampa, FL
29 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Tampa (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 2/3
- Moffitt Cancer Center /ID# 279192, Tampa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Menerima pesertaFase 3
- Moffit Cancer center, Tampa
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Menerima pesertaFase 3
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of BGB-11417 in Participants With Myeloid Malignancies
Menerima pesertaFase 1/2
- Tampa General Hospital, Tampa
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 1/2
- Moffitt Cancer Center and Research Institute Hospital, Tampa
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Menerima pesertaFase 1/2
- Moffitt Cancer Center, Tampa
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Menerima pesertaFase 3
- Saint Joseph's Hospital - Tampa, Tampa
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Menerima pesertaFase 3
- Moffitt Cancer Center & Research Institute, Tampa
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Menerima pesertaFase 1
- H Lee Moffitt Cancer Center & Research Institute, Tampa
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Menerima pesertaFase 3
- Moffitt Cancer Center, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Menerima pesertaFase 2
- Moffitt Cancer Center, Tampa
BCL2i CLAG-M in R/R Acute Myeloid Leukemia
Menerima pesertaFase 2
- Moffitt Cancer Center, Tampa
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Menerima pesertaFase 1/2
- Moffitt Cancer Center, Tampa
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Menerima pesertaFase 2
- Moffitt Cancer Center, Tampa
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
Menerima pesertaFase 2
- Moffitt Cancer Center, Tampa
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Menerima pesertaFase 1
- Moffitt, Tampa
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Menerima pesertaSukarelawan sehat diterima
- Moffitt Cancer Center, Tampa
Study of REM-422 in Patients With AML or Higher Risk MDS
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Chicago, IL26 studi
- Portland, OR25 studi
- Washington, DC24 studi
Studi lain di Tampa
- Kanker Paru Non-Sel Kecil51 studi
- Kanker Payudara43 studi
- Kanker (semua jenis)39 studi
- Kanker Kolorektal34 studi
- Kanker Metastatik29 studi
- Kanker Paru29 studi
- Kanker Pankreas26 studi
- Kanker Ovarium21 studi
- Melanoma19 studi
- Sindrom Mielodisplastik19 studi
- Kanker Prostat18 studi
- Gagal Jantung18 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.